Search results for: 'value us'

Microbiome research is on the rise following technological advancements and significant cost reductions in microbiome analysis. Research has unlocked the potential of microbiome in medical use cases, yielding tremendous insights on its nature, interactions, and impact within a host and in an external environment. Advanced studies on the role of mic...

Operational, clinical, and financial challenges that result in inefficient resource utilization and suboptimal healthcare outcomes waste money and time and ultimately affect payers and providers’ ability to focus on preventive care and population health improvement. Frost & Sullivan defines population health management (PHM) as solutions and serv...

Digitalization of the entire value chain will drive next-generation biomanufacturing. The industry is all set to move away from the traditional pen-and-paper-based process to a more advanced, digitized, track-and-trace process that is aligned toward Industry 4.0. Digital tools applied across processes, monitoring, analytics, and operations have acc...

This Frost & Sullivan research service discusses advances in AI integration in Molecular Diagnostics, highlights key advantages of incorporating AI in the diagnostics workflow and roadblocks that have prevented it from becoming mainstream. While AI is widely used in radiology- and pathology-based diagnostics, its adoption is gradually increasing in...

This study addresses the imaging services trends and challenges seen at various global outpatient imaging sites. The focus of this study addresses various imaging services provided using modalities such as fixed and portable X-ray and ultrasound devices as well as advanced imaging equipment such as mammography, CT, MRI, C-arm, and molecular imaging...

The biopharma industry has been evolving over the past few decades. This study analyses the top ten trends that will impact the future of the biopharma industry through 2040.The future of biopharma will be driven by innovation in AI and ML, particularly generative AI, and by advancements in translational medicine and synthetic biology. Future clini...

Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...

In this research deliverable, Frost & Sullivan’s senior analyst team across the healthcare sector provides bold perspectives and predictions for the industry in 2016. The markets covered include pharmaceuticals and biotech, medical devices, medical imaging, and healthcare IT, amongst others. The analysis captures the impact of trends that are expec...

30 Aug 2024  |  Global  |  Market Research

Population Health Management Sector, Global, 2024 2029

Operational and Financial Challenges are Driving Transformational Growth with the Shift toward Value-based Care

Infographics

×

Healthcare providers worldwide struggle with operational, financial, and clinical challenges on top of workforce scarcity. Payers are challenged with rising healthcare costs and shrinking margins. Payers, providers, and policymakers seek ways to curb these expenditures. Population health management (PHM) software that enables cost containment strat...